Voices
2026 Early Career Researcher Awardees Receive More Than $1 Million in Funding – PICI
Parker Institute for Cancer Immunotherapy

2026 Early Career Researcher Awardees Receive More Than $1 Million in Funding – PICI

Parker Institute for Cancer Immunotherapy (PICI), shared on X:

“Today, PICI announced its 2026 class of Early Career Researchers awardees. The investigators will receive more than $1 million in combined funding to advance innovative research projects that could help shape the next generation of cancer immunotherapies.

Meet the 2026 Early Career Researcher Awardees:

  • Sophie Louise Gray-Gaillard
  • Jingya Qiu
  • Xinyu Xiang
  • Shaobo Yang
  • Maxime Meylan

From programmable bacterial ‘living medicines’ and tumor-targeting T-cell therapies to new approaches for understanding the tumor microenvironment and detecting cancer earlier, these researchers are pursuing high-risk, high-reward science with the potential to transform cancer treatment.

Now in its 10th year, PICI’s Early Career Researcher Awards program has invested $23.9 million across 63 research projects, giving emerging scientists the funding, resources and collaborative network to turn bold ideas into breakthroughs.

Learn more.”

Other articles about Cancer Immunotherapy on OncoDaily.

cancer cancer immunotherapy Cancer immunotherapy research Cancer research cancer research funding Dana-Farber Cancer Institute Early Career Researcher Awards Early-career researchers Gladstone Institutes immuno-oncology Jingya Qiu Maxime Meylan OncoDaily Oncology Parker Institute for Cancer Immunotherapy Penn Medicine PICI Shaobo Yang Sophie Louise Gray-Gaillard Stanford Medicine T cell immunotherapy T-cell therapy tumor microenvironment University of Pennsylvania Xinyu Xiang